U. S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                   FORM 10-QSB
(Mark One)
[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
     OF 1934

For the quarter ended January 31, 2002
                      ----------------

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
     OF 1934
For  the  transition  period  from ___________ to ___________

Commission  File  No.  000-31027
                       ---------

                             AMAZON SCIENTIFIC INC.
                             ----------------------
                 (Name of Small Business Issuer in its Charter)

             Nevada                                           76-0602966
             ------                                           ----------
   (State or Other Jurisdiction of                         (I.R.S.  Employer
   incorporation  or  organization)                       Identification  No)

                          Suite 210, 580 Hornby Street
                          ----------------------------
                  Vancouver, British Columbia, Canada V6C 3B6
                    (Address of Principal Executive Offices)

                                 (604) 662-7000
                          ----------------------------
                            Issuer's Telephone Number

                                       N/A
                          ----------------------------
          (Former Name or Former Address, if changed since last Report)

Check  whether  the Issuer (1) filed all reports required to be filed by Section
13  or  15(d) of the Exchange Act during the past 12 months (or for such shorter
period  that  the  Company  was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past  90  days.

              (1)  Yes  X     No               (2)  Yes   X    No
                       ---       ---                     ---       ---

     (ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

                                 Not applicable

                     (APPLICABLE ONLY TO CORPORATE ISSUERS)

State the number of shares outstanding of each of the Issuer's classes of common
equity,  as  of  the  latest  practicable  date:

                                 March 27, 2002

                        Common - 2,500,000 common shares

                       DOCUMENTS INCORPORATED BY REFERENCE

A  description of any "Documents Incorporated by Reference" is contained in Item
6  of  this  Report.

Transitional Small Business Issuer Format       Yes  X     No
                                                    ---       ---


<PAGE>
<TABLE>
<CAPTION>
PART I - FINANCIAL INFORMATION

Item 1.     Financial Statements.

Amazon Scientific Inc.
(A Development Stage Company)
Interim Balance Sheet


                                                                   January 31,    April 30,
                                                                      2002          2001
                                                                        $             $
                                                                   (unaudited)    (audited)
<S>                                                               <C>            <C>
ASSETS                                                                       -            -
============================================================================================

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities

  Accounts payable                                                       5,917        2,460
  Accrued liabilities                                                      655          500
--------------------------------------------------------------------------------------------
Total Liabilities                                                        6,572        2,960
--------------------------------------------------------------------------------------------

Contingent Liability (Note 1)

Stockholders' Deficit

Common Stock: 25,000,000 shares authorized with a par value of           2,500        2,500
0.001; 2,500,000 shares issued and outstanding

Additional Paid-in Capital                                                 189          189
--------------------------------------------------------------------------------------------
                                                                         2,689        2,689

Deficit Accumulated During the Development Stage                        (9,261)      (5,649)
--------------------------------------------------------------------------------------------

Total Stockholders' Deficit                                             (6,572)      (2,960)
--------------------------------------------------------------------------------------------

Total Liabilities and Stockholders' Equity                                   -            -
============================================================================================
</TABLE>


                                      F-1

    (The accompanying notes are an integral part of the financial statements)

<PAGE>
<TABLE>
<CAPTION>
Amazon Scientific Inc.
(A Development Stage Company)
Interim Statements of Operations
(unaudited)


                                          Accumulated From
                                           April 2, 1999
                                        (Date of Inception)      Three months ended         Nine months ended
                                           to January 31,            January 31,                January 31,
                                                2002              2002         2001          2002          2001
                                                 $                 $             $            $             $
<S>                                     <C>                   <C>           <C>          <C>           <C>
Revenue                                                   -             -             -            -             -
-------------------------------------------------------------------------------------------------------------------

Expenses

   Accounting and legal                               5,083           (50)            -        2,523         1,500
   Amortization of license                            1,500             -             -            -             -
   Filing fees                                        1,489           360             -        1,089             -
   License written-off                                  500             -             -            -             -
   Organization expenses                                689             -             -            -             -
-------------------------------------------------------------------------------------------------------------------

Net Loss                                             (9,261)         (310)            -       (3,612)       (1,500)
===================================================================================================================

Net Loss Per Share (Basic and Diluted)                                  -             -            -             -
===================================================================================================================

Weighted Average Number of Shares                               2,500,000     2,500,000    2,500,000     2,500,000
Outstanding
===================================================================================================================

(Diluted  loss  per share has not been presented as the result is anti-dilutive)

</TABLE>

                                      F-2


    (The accompanying notes are an integral part of the financial statements)

<PAGE>
<TABLE>
<CAPTION>
Amazon Scientific Inc.
(A Development Stage Company)
Interim Statements of Cash Flows
(unaudited)


                                              Nine months ended
                                                 January 31,
                                                2002      2001
                                                 $         $
<S>                                           <C>       <C>
Cash Flows From Operating Activities

Net loss                                       (3,612)   (1,500)

Changes in operating assets and liabilities:

  Accounts payable and accrued liabilities      3,612     1,500
----------------------------------------------------------------

Net Cash Used by Operating Activities               -         -
----------------------------------------------------------------

Cash Flows From Financing Activities                -         -
----------------------------------------------------------------

Change In Cash                                      -         -

Cash at Beginning of Period                         -         -
----------------------------------------------------------------

Cash at End of Period                               -         -
================================================================

Non-Cash Financing Activities                       -         -
================================================================

Supplemental Disclosures

  Interest paid                                     -         -
  Income tax paid                                   -         -
</TABLE>

                                      F-3


    (The accompanying notes are an integral part of the financial statements)

<PAGE>
Amazon  Scientific  Inc.
A  Development  Stage  Company)
Notes  to  the  Interim  Financial  Statements
January  31,  2002
(unaudited)

1.   Nature of Operations and Continuance of Business

     Amazon Scientific Inc. herein (the "Company") was incorporated in the State
     of  Nevada,  U.S.A.  on  April  2,  1999. The Company acquired a license to
     market and distribute a product. As discussed in Note 3, this license is in
     jeopardy  and  the  Company  has  retained  the  right  to  sue the vendor.

     The  Company's  new  business plan is as a "blank check" company. Under the
     Securities  Act  of 1933, a blank check company is defined as a development
     stage  company  that  has  no  specific  business  plan  or  purpose or has
     indicated  that  its  business plan is to engage in a merger or acquisition
     with  an  unidentified  company  or  companies and is issuing "penny stock"
     securities.

     In  a  development stage company, management devotes most of its activities
     in  investigating business opportunities. Planned principal activities have
     not  yet  begun.  The ability of the Company to emerge from the development
     stage  with respect to any planned principal business activity is dependent
     upon  its  successful efforts to raise additional equity financing and find
     an  appropriate merger candidate. There is no guarantee that Amazon will be
     able to raise any equity financing or find an appropriate merger candidate.
     There is substantial doubt regarding the Company's ability to continue as a
     going  concern.


2.   Summary  of  Significant  Accounting  Policies

     (a)  Year End

          The  Company's  fiscal  year  end  is  April  30.

     (b)  Long Lived Assets

          The  carrying  value  of  long-lived  assets  are  evaluated  in  each
          reporting  period  to  determine if there were events or circumstances
          which  would  indicate  a  possible  inability to recover the carrying
          amount.  Such  evaluation  is  based  on  various  analyses  including
          assessing  the  Company's ability to bring the commercial applications
          to  market,  related  profitability  projections and undiscounted cash
          flows  relating  to  each  application  which  necessarily  involves
          significant  management  judgment.

     (c)  Cash  and  Cash  Equivalents

          The Company considers all highly liquid instruments with a maturity of
          three  months  or less at the time of issuance to be cash equivalents.

     (d)  Use of Estimates

          The  preparation  of financial statements in conformity with generally
          accepted  accounting  principles requires management to make estimates
          and  assumptions  that  affect  the  reported  amounts  of  assets and
          liabilities and disclosure of contingent assets and liabilities at the
          date  of the financial statements and the reported amounts of revenues
          and  expenses  during  the  periods.  Actual results could differ from
          those  estimates.


                                      F-4
<PAGE>
Amazon  Scientific  Inc.
A  Development  Stage  Company)
Notes  to  the  Interim  Financial  Statements
January  31,  2002
(unaudited)

2.   Summary of Significant Accounting Policies (continued)

     (e)  Interim Financial Statements

          These interim unaudited financial statements have been prepared on the
          same  basis  as  the annual financial statements and in the opinion of
          management,  reflect  all  adjustments,  which  include  only  normal
          recurring  adjustments,  necessary  to  present  fairly  the Company's
          financial  position,  results  of  operations  and  cash flows for the
          periods  shown.  The  results  of  operations for such periods are not
          necessarily  indicative of the results expected for a full year or for
          any  future  period.


3.  License

     The  Company's only asset was a license to distribute and produce an oxygen
     enriched  water  product,  called  "Biocatalyst,"  for  remediation  for
     aquiculture,  mariculture,  fish  farming,  and  the  like,  or  for use in
     aquariums and the rights accruing from this license. The Company's original
     business  plan  was  to  determine  the  feasibility  of  the  Biocatalyst
     remediation application, and, if Biocatalyst proved to be feasible for this
     application,  become  a  Biocatalyst  producer.  The  Company  acquired the
     three-year  license from Mortenson & Associates on April 5, 1999 by issuing
     2,000,000  shares  at  a  fair market value of $.001 or $2,000. The general
     partner of Mortenson & Associates was also a former director and officer of
     the  Company.  Mortenson  &  Associates  acquired  its  right to sublicense
     Biocatalyst  to  the  Company  from  NW  Technologies.

     In  December,  1999, David R. Mortenson, Mortenson & Associates' principal,
     notified  the  Company  that  he  was  involved  in a legal dispute with NW
     Technologies,  and  would  be  unable  to fulfill his obligations under the
     license to the Company. As a result, the Company's ability to implement its
     business  plan was seriously undermined, and the Company never filed a Form
     S-1  Registration  Statement.  The Company has no plan to pursue a claim at
     this  time.


4.  Related  Party  Transaction

     The  License referred to in Note 3 was sold to the Company by a partnership
     whose  general  manager  was  the  former  President  of  the Company and a
     director  for  consideration  of  2,000,000  shares  for  total fair market
     consideration of $2,000. These shares were paid evenly to the ten partners.


                                      F-5
<PAGE>
Amazon  Scientific  Inc.
A  Development  Stage  Company)
Notes  to  the  Interim  Financial  Statements
January  31,  2002
(unaudited)

Item  2.     Management's  Discussion  and  Analysis  or  Plan  of  Operation
-----------------------------------------------------------------------------

The  following  discussion  and  analysis  of Amazon Scientific Inc.'s financial
condition  and  results  of  operations  should  be read in conjunction with the
Financial  Statements and accompanying notes and the other financial information
appearing  elsewhere  in  this  report.

Plan  of  Operation
-------------------

The  Company has not engaged in any material operations or had any revenues from
operations since its inception on April 2, 1999. The Company's plan of operation
for  the  next  12  months  is  to  continue  to seek the acquisition of assets,
properties  or  businesses  that  may  benefit the Company and its stockholders.
Management  anticipates  that  to achieve any such acquisition, the Company will
issue  shares  of  its  common  stock  as  the  sole  consideration for any such
acquisition.  During  the  next  12  months, the Company's only foreseeable cash
requirements  will  relate  to  maintaining  the Company in good standing or the
payment  of  expenses  associated  with reviewing or investigating any potential
business  ventures.  Such funds may be advanced by management or stockholders as
loans  to  the Company. Because the Company has not identified any such ventures
as  of  the  date  of this Report, it is impossible to predict the amount of any
such  loans  or  advances. However, any such loans or advances should not exceed
$25,000  and  will  be  on terms no less favourable to the Company than would be
available  from  a  commercial  lender in an arm's length transaction. As of the
date  of this Report, the Company is not involved in any negotiations respecting
any  such  ventures.

Results  of  Operations
-----------------------

Other  than  maintaining  its  good  corporate  standing in the State of Nevada,
seeking the acquisition of assets, properties or businesses that may benefit the
Company  and  its  stockholders,  the  Company  has  had  no  material  business
operations  since  its  inception in April, 1999, or during the six months ended
January  31,  2002  or  2001.

During  the quarterly periods ended January 31, 2002 or 2001, the Company had no
significant  business  operations.

Liquidity
---------

The Company had no cash on hand at January 31, 2002. Management does not believe
that this will be sufficient to meet its anticipated expenses during the next 12
months.  The  Company  will  have to raise additional funds through sales of its
securities  or  through  loans  from  stockholders  or  management.


                                      F-6
<PAGE>
PART  II  -  OTHER  INFORMATION

Item  1.     Legal  Proceedings.

             None;  not  applicable.

Item  2.     Changes  in  Securities.

             None;  not  applicable.

Item  3.     Defaults  Upon  Senior  Securities.

             None;  not  applicable.

Item  4.     Submission  of  Matters  to  a  Vote  of  Security  Holders.

             None;  not  applicable.

Item  5.     Other  Information.

             None;  not  applicable.

Item  6.     Exhibits  and  Reports  on  Form  8-K.

             None.


             DOCUMENTS  INCORPORATED  BY  REFERENCE

             None.


                                      F-7
<PAGE>
                                   SIGNATURES

Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
Registrant  has  duly  caused  this  Report  to  be  signed on its behalf by the
undersigned  thereunto  duly  authorized.

                                       AMAZON SCIENTIFIC INC.

Date:  March 27, 2002                  By:  /s/ Frank Roberts
       ---------------------                ------------------------
                                            Frank Roberts, President

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
this  Report  has  been  signed  below by the following persons on behalf of the
Company  and  in  the  capacities  and  on  the  dates  indicated:

Date:  March 27, 2002                  By:  /s/ Frank Roberts
       ---------------------                ------------------------
                                            Frank Roberts, President


Date:  March 27, 2002                  By:  /s/ Richard Achron
       ---------------------                ------------------------
                                            Richard Achron, Director,
                                            Treasurer and Secretary


                                      F-8
<PAGE>